Handbook of Neuroengineering 2022
DOI: 10.1007/978-981-15-2848-4_120-1
|View full text |Cite
|
Sign up to set email alerts
|

Central and Peripheral Neural Interfaces for Control of Upper Limb Actuators for Motor Rehabilitation After Stroke: Technical and Clinical Considerations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 204 publications
0
1
0
Order By: Relevance
“…Concluding, cortico-muscular interfaces that estimate source related CMC might have a greater potential for reinforcing efferent pathways from cortical motor structures to the targeted paralyzed muscles and have therefore been suggested as a promising approach for stroke motor rehabilitation (Irastorza-Landa et al, 2022 ). Furthermore, despite the promising preliminary results presented in this section, further work evaluating the changes in CMC levels in larger stroke patient cohorts enrolled in NI related therapy is needed to demonstrate a direct relationship with gained motor functions, hence, more controlled clinical trials are needed to test neuro-muscular interfaces in stroke survivors.…”
Section: Biotargets For Rehabilitative Neural Interfacesmentioning
confidence: 99%
“…Concluding, cortico-muscular interfaces that estimate source related CMC might have a greater potential for reinforcing efferent pathways from cortical motor structures to the targeted paralyzed muscles and have therefore been suggested as a promising approach for stroke motor rehabilitation (Irastorza-Landa et al, 2022 ). Furthermore, despite the promising preliminary results presented in this section, further work evaluating the changes in CMC levels in larger stroke patient cohorts enrolled in NI related therapy is needed to demonstrate a direct relationship with gained motor functions, hence, more controlled clinical trials are needed to test neuro-muscular interfaces in stroke survivors.…”
Section: Biotargets For Rehabilitative Neural Interfacesmentioning
confidence: 99%